A Study to Compare Pharmacokinetics and Pharmacodynamics of RinGlar® to Lantus® in Type 1 Diabetes Mellitus Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
Pharmacokinetics and pharmacodynamics study of 2 formulation of insulin glargine (RinGlar® GEROPHARM vers. Lantus® Sanofi-Aventis)
Epistemonikos ID: ade3c2f679cf4d8d87c20c5d0a8197fb40ed8e6a
First added on: May 22, 2024